JPY 555.0
(-0.54%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 1.11 Billion JPY | 39.5% |
2022 | 1.03 Billion JPY | 37.68% |
2021 | 553.75 Million JPY | 96.37% |
2020 | 326.89 Million JPY | -24.25% |
2019 | 441.6 Million JPY | -9.42% |
2018 | 481.61 Million JPY | -82.26% |
2017 | 757.31 Million JPY | 4.11% |
2016 | 776.07 Million JPY | -5.42% |
2015 | 767.91 Million JPY | 13.8% |
2014 | 739.03 Million JPY | 10.17% |
2013 | 1.16 Billion JPY | 96.11% |
2012 | 929.22 Million JPY | -29.5% |
2011 | 1.32 Billion JPY | -2.9% |
2010 | 1.33 Billion JPY | 17.06% |
2009 | 1.14 Billion JPY | 17.88% |
2008 | 958.98 Million JPY | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | 369.27 Million JPY | 39.04% |
2024 Q1 | 387.59 Million JPY | 603.89% |
2024 Q3 | 236.68 Million JPY | -37.25% |
2023 Q4 | 102 Million JPY | -74.51% |
2023 FY | - JPY | 39.5% |
2023 Q1 | 91.95 Million JPY | 180.62% |
2023 Q2 | 403.78 Million JPY | 339.1% |
2023 Q3 | 400.22 Million JPY | -0.88% |
2022 Q1 | 251.79 Million JPY | 3131.87% |
2022 Q2 | 259.1 Million JPY | 2.9% |
2022 FY | - JPY | 37.68% |
2022 Q3 | 212.09 Million JPY | -18.14% |
2022 Q4 | -114.06 Million JPY | -153.78% |
2021 Q3 | 86.77 Million JPY | -3.06% |
2021 FY | - JPY | 96.37% |
2021 Q1 | 176.74 Million JPY | 260.78% |
2021 Q2 | 89.51 Million JPY | -49.35% |
2021 Q4 | -8.3 Million JPY | -109.57% |
2020 Q1 | 172.03 Million JPY | 440.18% |
2020 FY | - JPY | -24.25% |
2020 Q4 | -109.92 Million JPY | -229.96% |
2020 Q3 | 84.58 Million JPY | 248.15% |
2020 Q2 | 24.29 Million JPY | -85.88% |
2019 FY | - JPY | -9.42% |
2019 Q1 | 116.89 Million JPY | 270.92% |
2019 Q4 | 31.84 Million JPY | -44.23% |
2019 Q3 | 57.1 Million JPY | -45.62% |
2019 Q2 | 105 Million JPY | -10.18% |
2018 Q4 | -68.39 Million JPY | -163.92% |
2018 Q3 | 106.99 Million JPY | 15.88% |
2018 Q2 | 92.32 Million JPY | -31.42% |
2018 Q1 | 134.62 Million JPY | -92.68% |
2018 FY | - JPY | -82.26% |
2017 Q4 | 1.83 Billion JPY | 1250.45% |
2017 Q2 | 60.11 Million JPY | -80.87% |
2017 FY | - JPY | 4.11% |
2017 Q1 | 314.31 Million JPY | -83.83% |
2017 Q3 | 136.2 Million JPY | 126.56% |
2016 Q1 | 174.33 Million JPY | -90.72% |
2016 Q4 | 1.94 Billion JPY | 1140.81% |
2016 FY | - JPY | -5.42% |
2016 Q3 | 156.64 Million JPY | 870.25% |
2016 Q2 | -20.33 Million JPY | -111.67% |
2015 Q1 | 194.94 Million JPY | -88.22% |
2015 FY | - JPY | 13.8% |
2015 Q4 | 1.87 Billion JPY | 764.62% |
2015 Q3 | 217.31 Million JPY | 181.34% |
2015 Q2 | 77.24 Million JPY | -60.38% |
2014 Q2 | 178.02 Million JPY | 20.71% |
2014 Q1 | 147.48 Million JPY | -90.35% |
2014 Q3 | 63.12 Million JPY | -64.54% |
2014 FY | - JPY | 10.17% |
2014 Q4 | 1.65 Billion JPY | 2521.3% |
2013 Q3 | 73.7 Million JPY | -55.64% |
2013 Q4 | 1.52 Billion JPY | 1972.93% |
2013 Q2 | 166.13 Million JPY | 11.86% |
2013 Q1 | 148.52 Million JPY | -43.97% |
2013 FY | - JPY | 96.11% |
2012 Q2 | 286.84 Million JPY | 0.75% |
2012 Q1 | 284.69 Million JPY | -34.55% |
2012 Q4 | 265.09 Million JPY | 123.11% |
2012 Q3 | 118.81 Million JPY | -58.58% |
2012 FY | - JPY | -29.5% |
2011 Q4 | 434.97 Million JPY | 84.9% |
2011 Q1 | 427.14 Million JPY | -16.92% |
2011 FY | - JPY | -2.9% |
2011 Q3 | 235.24 Million JPY | -48.73% |
2011 Q2 | 458.84 Million JPY | 7.42% |
2010 FY | - JPY | 17.06% |
2010 Q1 | 364.27 Million JPY | 12.91% |
2010 Q3 | 273.07 Million JPY | -39.51% |
2010 Q2 | 451.46 Million JPY | 23.93% |
2010 Q4 | 514.15 Million JPY | 88.28% |
2009 Q2 | 336.6 Million JPY | 0.0% |
2009 Q4 | 322.62 Million JPY | 16.18% |
2009 Q3 | 277.68 Million JPY | -17.5% |
2009 FY | - JPY | 17.88% |
2008 FY | - JPY | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Kitanotatsujin Corporation | 1.58 Billion JPY | 30.084% |
Euglena Co., Ltd. | 676 Million JPY | -64.23% |
BEAUTY GARAGE Inc. | 1.96 Billion JPY | 43.497% |
Axas Holdings Co.,Ltd. | 555.75 Million JPY | -99.762% |
C.I. Medical Co.,Ltd. | 4.01 Billion JPY | 72.335% |
Kao Corporation | 154.49 Billion JPY | 99.281% |
Niitaka Co., Ltd. | 1.36 Billion JPY | 18.936% |
Rohto Pharmaceutical Co.,Ltd. | 48.85 Billion JPY | 97.728% |
Shiseido Company, Limited | 106.46 Billion JPY | 98.957% |
Lion Corporation | 42.31 Billion JPY | 97.376% |
Mandom Corporation | 6.69 Billion JPY | 83.427% |
Ivy Cosmetics Corporation | 242.6 Million JPY | -357.624% |
Milbon Co., Ltd. | 7.8 Billion JPY | 85.767% |
Nippon Shikizai, Inc. | 1.28 Billion JPY | 13.843% |
Fancl Corporation | 16.6 Billion JPY | 93.313% |
KOSÉ Corporation | 26.85 Billion JPY | 95.866% |
Cota Co., Ltd. | 2.26 Billion JPY | 51.06% |
HABA Laboratories,Inc. | -1.31 Billion JPY | 184.47% |
C'bon Cosmetics Co.,Ltd. | 171.84 Million JPY | -546.037% |
Pola Orbis Holdings Inc. | 23.17 Billion JPY | 95.21% |
Noevir Holdings Co., Ltd. | 12.24 Billion JPY | 90.933% |
Adjuvant Holdings Co.,Ltd. | 124 Million JPY | -795.319% |
Almado, Inc. | 983.21 Million JPY | -12.915% |
I-ne CO., LTD. | 4.7 Billion JPY | 76.379% |
Premier Anti-Aging Co., Ltd. | -627 Million JPY | 277.065% |
Liberta Co.,Ltd. | 318.19 Million JPY | -248.908% |
AXXZIA Inc. | 1.28 Billion JPY | 13.705% |
S.T. Corporation | 2.62 Billion JPY | 57.723% |
Kobayashi Pharmaceutical Co., Ltd. | 31.68 Billion JPY | 96.496% |
Earth Corporation | 10.6 Billion JPY | 89.534% |
Sagami Rubber Industries Co., Ltd. | 1.09 Billion JPY | -1.43% |
Asahi Eito Holdings Co.,Ltd. | -573.98 Million JPY | 293.42% |
Ya-Man Ltd. | 1.43 Billion JPY | 22.73% |
MTG Co., Ltd. | 4.39 Billion JPY | 74.734% |
TRANSACTION CO.,Ltd. | 5.8 Billion JPY | 80.889% |
Artnature Inc. | 3.78 Billion JPY | 70.684% |
Pigeon Corporation | 15.8 Billion JPY | 92.976% |
Unicharm Corporation | 178.01 Billion JPY | 99.376% |
Paltac Corporation | 35.92 Billion JPY | 96.91% |
CB GROUP MANAGEMENT Co., Ltd. | 3.28 Billion JPY | 66.204% |